Floatz logo

CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE

Hepatocellular Carcinoma

National Health Research Institutes, TaiwanSmall moleculePhase 1/2Dormant
CC
41/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
65/ 100

Competitive context

263 Active assets in the Hepatocellular Carcinoma cohort.

Asset / SponsorPhaseRating
Theprubicin
RWTH Aachen University
Phase 4BB
Inno-206
VA Office of Research and Development
Phase 4BB
Ethiodized Oil
RWTH Aachen University
Phase 4BB
FLUOROURACILUM
Li Qiang
Phase 4BB
Calcium folinate pentahydrate
Li Qiang
Phase 4BB

View all 50 →

Same molecule, other indications

CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE is also rated in:

infantile spasmsDormant
BBB
Indicative ·
79 / 100
View asset →
non-Hodgkin lymphomaDormant
BBB
Indicative ·
74 / 100
View asset →
castration-resistant prostate carcinomaDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →